Remdesivir, an antiviral drug, was originally developed to treat Ebola and hepatitis C.
While dexamethasone has shown effectiveness, it cannot be used early in Covid-19 patients because it can weaken a person’s immune system, making it hard for a person to fight off the infection.
Two of the widely used drugs in the fight against Covid-19 do not prevent death or reduce the time spent in hospital.
According to the World Health Organization (WHO), only dexamethasone has shown effectiveness in treating severe Covid-19 cases.
